Indonesian government says 1.2 million doses of KOVID-19 vaccine developed by Chinese biopharmaceutical company Sinovac Bioteh arrived in the country late Sunday
JAKARTA, Indonesia – The Indonesian government says 1.2 million doses of the COVID-19 vaccine developed by Chinese biopharmaceutical company Sinovac Biotech arrived in the country late Sunday.
President Yoko Widodo said in a televised address that another 1.8 million doses of the vaccine were expected to arrive in early January.
“We are very grateful, thank God, the vaccine is now available so we can immediately stop the spread of KOVID-19 disease,” Vidodo said.
The government is still waiting for millions of other doses of the Sinovac vaccine to arrive in the form of raw materials to be further processed by the state-owned pharmaceutical holding company PT Bio Pharma.
However, Widodo said an emergency use authorization was still needed from the country’s Food and Drug Administration to launch mass vaccinations.
Indonesia is already cooperating with Sinovac in phase 3 clinical trials of its vaccine candidate, with tests conducted on 1,620 volunteers in the West Java city of Bandung since August. The government is also considering partnerships with two other Chinese drugmakers, Sinofarm and KanSino Biological.
Penny Lukito, head of the Food and Drug Administration, estimated that the Sinovac vaccine would receive approval for emergency use from the agency by the third or fourth week of January, after the agency evaluates the provisional results of the third phase clinical trial.